Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	322.80	-192.91	45.63
Graham Fair Price	47.32	802.51	544.74
PEG	-70.39	-0.04	0.14
Price/Book	-3.08	2.05	2.11
Price/Cash Flow	inf	0.00	-24.20
Prices/Earnings	-49.31	13.03	-25.71
Price/Sales	23102.29	604.47	2.61
Price/FCF	inf	0.00	-24.20
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-54.49	0.22	0.49
Operating Margin	61212.48	-7.16	0.01
ROA	95.75	0.02	< 0.005
ROE	-0.02	0.04	91.20
ROIC	-0.09	-0.02	72.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.99	0.31	224.38
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.77	-3.66	-376.94
EPS QOQ	-1.77	3.04	71.19
FCF QOQ	-1.97	1.00	-49.22
Revenue QOQ	0.18	-1.00	464.34
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.76	31065.89	196957.62
Days Sales Outstanding (DSO)	62.86	129.27	105.67
Inventory Turnover	5.71	< 0.005	-99.95
Debt/Capitalization	0.34	< 0.005	-98.97
Quick Ratio	0.76	0.05	-93.91
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	801.55	853.97	6.54
Cash	264.94	40.35	-84.77
Capex	-103.19	0.00	inf
Free Cash Flow	-69.92	0.00	inf
Revenue	649.59	2.89	-99.55
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.89	0.86	-3.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.91	4.06	-41.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating